A3334
A3051 is a potent and orally active inhibtor of CXXC5-DVL extracted from patent WO2020079569, has an IC50 of 63.06 nM. A3334 can be used for the research of high fat diet (HFD) -induced and methionine-choline deficient diet (MCD) -induced phenotypes such as obesity, diabetes, and NASH[1].
Product Specifications
CAS Number
854171-31-6
UNSPSC
12352005
Target
Wnt; β-catenin
Type
Reference compound
Related Pathways
Stem Cell/Wnt
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/a3334.html
Purity
99.64
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C1NC2=C(C=C(OC)C=C2)/C1=C3NC4=C(C=CC=C4)C/3=N/O
Molecular Formula
C17H13N3O3
Molecular Weight
307.30
References & Citations
[1]Choi KY, et, al. Compositions and methods for suppressing and/or treating metabolic diseases and/or a clinical condition thereof. WO2020079569.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD61 / Integrin 3 / Platelet Glycoprotein IIIa (Platelet Marker) (ITGB3/2597), CF405S conjugate, 0.1mg/mL
HER-2 / CD340 (HRB2/282), CF647 conjugate, 0.1mg/mL
Rat Sialidase 2, Cytosolic (SIAL2) ELISA Kit